Literature DB >> 23391668

Medical management and strategies to prevent coronary artery disease in patients with type 2 diabetes mellitus.

Mae Sheikh-Ali1, Prafull Raheja, Nancy Borja-Hart.   

Abstract

Coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM) is associated with increased immediate and long-term mortality compared with patients without T2DM. The amplified incidence of CAD stems partly from the aggregation of multiple risk factors, such as obesity, dyslipidemia, and hypertension, which occur in this population. In addition, there appear to be increased forces at play at the molecular and vascular levels in these individuals, which is evidenced by the increased thrombosis and inflammation that is seen in those with diabetic atherosclerosis. Hence, there is a growing need to emphasize early and vigilant risk factor management in patients with T2DM to help reduce their burden of cardiovascular-related mortality. In this article, we review the primary and secondary prevention measures as well as the management of CAD in patients with T2DM.

Entities:  

Mesh:

Year:  2013        PMID: 23391668     DOI: 10.3810/pgm.2013.01.2621

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  5 in total

1.  Long-term improvement of arterial wall characteristics in patients with diabetes mellitus type 1 using cyclic, intermittent treatment with a low-dose fluvastatin and valsartan combination.

Authors:  Vedran Savić; Miodrag Janić; Mojca Lunder; Karin Kanc; Andrej Janež; Barbara Eržen; Mišo Šabovič
Journal:  Exp Ther Med       Date:  2015-07-07       Impact factor: 2.447

Review 2.  Dapagliflozin in patients with type 2 diabetes mellitus.

Authors:  Theodosios D Filippatos; Evangelos N Liberopoulos; Moses S Elisaf
Journal:  Ther Adv Endocrinol Metab       Date:  2015-02       Impact factor: 3.565

Review 3.  Effects of glucagon-like peptide-1 receptor agonists on renal function.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Diabetes       Date:  2013-10-15

4.  Exercise electrocardiogram testing in two brothers with different outcome - a case study exercise testing in master cyclists.

Authors:  Christoph Alexander Rüst; Beat Knechtle; Thomas Rosemann
Journal:  Int J Gen Med       Date:  2013-06-17

5.  Increased chitotriosidase activity in plasma of patients with type 2 diabetes.

Authors:  Ewa Żurawska-Płaksej; Maria Knapik-Kordecka; Anna Rorbach-Dolata; Agnieszka Piwowar
Journal:  Arch Med Sci       Date:  2016-05-20       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.